Which has preferable earnings & valuation, XOMAP or ALVOW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio XOMA $7.65M N/A N/A N/A N/A Alvotech $491.95M N/A N/A N/A N/A

Is XOMAP or ALVOW more profitable?

Company Net Margins Return on Equity Return on Assets XOMA N/A N/A N/A Alvotech N/A N/A N/A

Which has stronger valuation & earnings, XOMAP or APLMW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio XOMA $7.65M N/A N/A N/A N/A Apollomics N/A N/A N/A N/A N/A

Is XOMAP or APLMW more profitable?

Company Net Margins Return on Equity Return on Assets XOMA N/A N/A N/A Apollomics N/A N/A N/A

Which has preferable earnings & valuation, XOMAP or BIAFW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio XOMA $7.65M N/A N/A N/A N/A bioAffinity Technologies $5.85M N/A N/A N/A N/A

Is XOMAP or BIAFW more profitable?

Company Net Margins Return on Equity Return on Assets XOMA N/A N/A N/A bioAffinity Technologies N/A N/A N/A

Which has higher valuation & earnings, BIVIW or XOMAP?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BioVie N/A N/A N/A N/A N/A XOMA $7.65M N/A N/A N/A N/A

Is BIVIW or XOMAP more profitable?

Company Net Margins Return on Equity Return on Assets BioVie N/A N/A N/A XOMA N/A N/A N/A

Which has preferable valuation & earnings, CDIOW or XOMAP?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cardio Diagnostics $14.45K N/A N/A N/A N/A XOMA $7.65M N/A N/A N/A N/A

Is CDIOW or XOMAP more profitable?

Company Net Margins Return on Equity Return on Assets Cardio Diagnostics N/A N/A N/A XOMA N/A N/A N/A

XOMA (XOMAP) Competitors

$24.98 0.00 (0.00%)

As of 11/6/2026

Compare

XOMAP vs. ALVOW, APLMW, BIAFW, BIVIW, and CDIOW

Should you buy XOMA stock or one of its competitors? XOMA's main competitors and comparable companies include Alvotech (ALVOW), Apollomics (APLMW), bioAffinity Technologies (BIAFW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does XOMA compare to Alvotech?

XOMA (NASDAQ:XOMAP) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

In the previous week, Alvotech had 8 more articles in the media than XOMA. MarketBeat recorded 8 mentions for Alvotech and 0 mentions for XOMA. XOMA's average media sentiment score of 0.00 beat Alvotech's score of -0.02 indicating that XOMA is being referred to more favorably in the media.

Company	Overall Sentiment
XOMA	Neutral
Alvotech	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
XOMA	$7.65M	N/A	N/A	N/A	N/A
Alvotech	$491.95M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
XOMA	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

Summary

Alvotech beats XOMA on 2 of the 3 factors compared between the two stocks.

How does XOMA compare to Apollomics?

XOMA (NASDAQ:XOMAP) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment and valuation.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
XOMA	$7.65M	N/A	N/A	N/A	N/A
Apollomics	N/A	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
XOMA	N/A	N/A	N/A
Apollomics	N/A	N/A	N/A

In the previous week, Apollomics had 1 more articles in the media than XOMA. MarketBeat recorded 1 mentions for Apollomics and 0 mentions for XOMA. Apollomics' average media sentiment score of 1.79 beat XOMA's score of 0.00 indicating that Apollomics is being referred to more favorably in the news media.

Company	Overall Sentiment
XOMA	Neutral
Apollomics	Very Positive

Summary

Apollomics beats XOMA on 2 of the 3 factors compared between the two stocks.

How does XOMA compare to bioAffinity Technologies?

XOMA (NASDAQ:XOMAP) and bioAffinity Technologies (NASDAQ:BIAFW) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
XOMA	$7.65M	N/A	N/A	N/A	N/A
bioAffinity Technologies	$5.85M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
XOMA	N/A	N/A	N/A
bioAffinity Technologies	N/A	N/A	N/A

In the previous week, bioAffinity Technologies had 2 more articles in the media than XOMA. MarketBeat recorded 2 mentions for bioAffinity Technologies and 0 mentions for XOMA. bioAffinity Technologies' average media sentiment score of 1.25 beat XOMA's score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
XOMA	Neutral
bioAffinity Technologies	Positive

Summary

bioAffinity Technologies beats XOMA on 2 of the 3 factors compared between the two stocks.

How does XOMA compare to BioVie?

BioVie (NASDAQ:BIVIW) and XOMA (NASDAQ:XOMAP) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, media sentiment, analyst recommendations and dividends.

Company	Net Margins	Return on Equity	Return on Assets
BioVie	N/A	N/A	N/A
XOMA	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioVie	N/A	N/A	N/A	N/A	N/A
XOMA	$7.65M	N/A	N/A	N/A	N/A

In the previous week, BioVie had 2 more articles in the media than XOMA. MarketBeat recorded 2 mentions for BioVie and 0 mentions for XOMA. BioVie's average media sentiment score of 0.39 beat XOMA's score of 0.00 indicating that BioVie is being referred to more favorably in the media.

Company	Overall Sentiment
BioVie	Neutral
XOMA	Neutral

Summary

BioVie beats XOMA on 2 of the 3 factors compared between the two stocks.

How does XOMA compare to Cardio Diagnostics?

Cardio Diagnostics (NASDAQ:CDIOW) and XOMA (NASDAQ:XOMAP) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, valuation, institutional ownership, analyst recommendations and media sentiment.

Company	Net Margins	Return on Equity	Return on Assets
Cardio Diagnostics	N/A	N/A	N/A
XOMA	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardio Diagnostics	$14.45K	N/A	N/A	N/A	N/A
XOMA	$7.65M	N/A	N/A	N/A	N/A

In the previous week, Cardio Diagnostics had 1 more articles in the media than XOMA. MarketBeat recorded 1 mentions for Cardio Diagnostics and 0 mentions for XOMA. Cardio Diagnostics' average media sentiment score of 1.79 beat XOMA's score of 0.00 indicating that Cardio Diagnostics is being referred to more favorably in the media.

Company	Overall Sentiment
Cardio Diagnostics	Very Positive
XOMA	Neutral

Summary

Cardio Diagnostics beats XOMA on 2 of the 3 factors compared between the two stocks.

Get XOMA News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XOMAP vs. The Competition

Export

Metric	XOMA	Biotechnology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$4.08B	$7.83B	$12.14B
Dividend Yield	9.29%	3.62%	2.46%	4.51%
P/E Ratio	N/A	24.51	34.53	30.54
Price / Sales	N/A	16.94	8.92	5.91
Price / Cash	N/A	26.89	22.23	22.80
Price / Book	N/A	4.12	4.39	3.80
Net Income	N/A	-$22.78M	$3.51B	$390.69M
7 Day Performance	N/A	-2.80%	-1.39%	0.04%
1 Month Performance	N/A	-5.70%	-3.74%	-6.37%
1 Year Performance	-5.30%	-0.36%	1.07%	-5.63%

XOMA Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XOMAP XOMA	N/A	$24.98 flat	N/A	N/A	$0.00	$7.65M	N/A	10	News Coverage
ALVOW Alvotech	N/A	$0.14 -6.7%	N/A	-84.7%	$0.00	$491.95M	N/A	1,460	Short Interest Increase Gap Down
APLMW Apollomics	N/A	$0.01 -15.8%	N/A	-47.2%	$0.00	$8.50M	N/A	15	Gap Down
BIAFW bioAffinity Technologies	N/A	$0.20 -19.1%	N/A	-25.4%	$0.00	$5.85M	N/A	57	Upcoming Earnings
BIVIW BioVie	N/A	$0.27 +6.2%	N/A	N/A	$0.00	N/A	N/A	13	Short Interest Increase Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XOMAP) was last updated on 11/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

XOMA (XOMAP) Competitors